Efficacy of the protocol for the selection of anticoagulants in hemodialysis

Evaluation of a protocol-based management of anticoagulants in hemodialysis during invasive procedure - Protocol-Based Control of anticoagulants in hemodialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055094

Enrollment

350

Registered

2024-07-28

Start date

2024-03-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients in hemodialysis during invasive procedure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hemodialysis patients admitted to our hospital for invasive procedure.

Exclusion criteria

Exclusion criteria: Cases in which disapproval of this study was offered based on the information Cases in which invasive procedures were not performed

Design outcomes

Primary

Measure	Time frame
Compliance with the protocol for changing anticoagulants in hemodialysis	—

Secondary

Measure	Time frame
Complications in patients in hemodialysis during invasive procedure Types and dosages of anticoagulants used in hemodialysis	—

Countries

Japan

Contacts

Public ContactKentaro Nakai

Japanese Red Cross Fukuoka Hospital Division of Nephrology and Dialysis Center

k-nakai@fukuoka-med.jrc.or.jp092-521-1211

Outcome results